China Resources Pharmaceutical Group Ltd. (640) AI Stock Analysis
China Resources Pharmaceutical Group Ltd.
(Frankfurt:640)
No summary available
China Resources Pharmaceutical Group Ltd. (640) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 3.32B
- Dividend Yield
- 4.96%
- Average Volume (3M)
- 21.45K
- Price to Earnings (P/E)
- 6.2
- Beta (1Y)
- 0.32
- Revenue Growth
- 0.35%
- EPS Growth
- 42.46%
- Country
- Germany
- Employees
- 84,000
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
China Resources Pharmaceutical Group Ltd. Business Overview & Revenue Model
Company Description
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments...
China Resources Pharmaceutical Group Ltd. Peers Comparison
Overall Rating
HK:151377Outperform
HK:086761Neutral
HK:393358.2Neutral
HK:087457Neutral
HK:219657Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:1513 | 77Outperform | HKD 26.72B | 16.30 | 11.32% | 6.71% | -9.56% | -23.22% |
| HK:0867 | 61Neutral | HKD 23.94B | 13.40 | 8.60% | 3.50% | 14.80% | -2.88% |
| HK:3933 | 58Neutral | HKD 13.46B | 20.80 | 3.12% | 4.38% | -12.86% | -83.10% |
| HK:0874 | 57Neutral | HKD 35.32B | 14.74 | 5.57% | 6.71% | 6.00% | -23.05% |
| HK:2196 | 57Neutral | HKD 65.63B | 17.04 | 7.14% | 2.73% | 9.88% | 9.30% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:640 | China Resources Pharmaceutical Group Ltd. | 0.52 | -0.00 | -0.19% | |
| HK:3933 | The United Laboratories International | 6.83 | -5.69 | -45.46% | |
| HK:0867 | China Medical System Holdings | 9.81 | -3.65 | -27.10% | |
| HK:0874 | Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H | 12.86 | -5.10 | -28.41% | |
| HK:1513 | Livzon Pharmaceutical Group Class H | 23.18 | -5.02 | -17.81% | |
| HK:2196 | Shanghai Fosun Pharmaceutical (Group) Co Class H | 16.47 | -6.58 | -28.55% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.